NASDAQ:INM
InMed Pharmaceuticals Inc.
- Stock
Last Close
0.29
20/05 20:00
Market Cap
2.41M
Beta: 1.06
Volume Today
39.64K
Avg: 631.00K
PE Ratio
−0.16
PFCF: −0.24
Jun '13 | Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -477.90M - | -476.66M 0.26% | 2.05M 100.43% | |||||||||
average payables | 37.12K - | 43.68K 17.69% | 57.82K 32.37% | 147.31K 154.77% | 260.47K 76.82% | 498.63K 91.43% | 951.75K 90.87% | 595.24K 37.46% | 387.56K 34.89% | 970.60K 150.44% | 855.12K 11.90% | |
average receivables | 1.11K - | 11.54K 934.83% | 26.57K 130.31% | 48.20K 81.40% | 55.64K 15.42% | 43.03K 22.66% | 52.66K 22.38% | 54.99K 4.43% | 28.58K 48.02% | 49.97K 74.84% | 174.21K 248.61% | |
book value per share | -1.08 - | 36.24 3,455.19% | 22.83 37.01% | 10.42 54.34% | 56.49 441.97% | 119.45 111.43% | 67.03 43.88% | 26.72 60.14% | 27.44 2.70% | 16.19 41.01% | 4.94 69.46% | |
capex per share | -0.05 - | -0.09 78.70% | -0.01 86.01% | -0.18 1,384.64% | -0.25 36.06% | -0.13 46.72% | -0.20 53.54% | -0.01 96.80% | -0.07 986.59% | -0.07 5.11% | ||
capex to depreciation | -50.49 - | -0.06 99.87% | -0.01 79.47% | -0.26 1,877.17% | -0.47 81.88% | -0.29 39.55% | -0.26 9.47% | -0.01 94.48% | -0.08 435.42% | -0.27 255.28% | ||
capex to operating cash flow | 0.00 - | 0.00 5.00% | 0.00 23.94% | 0.01 260.08% | 0.01 44.28% | 0.00 66.01% | 0.01 44.59% | 0.00 96.99% | 0.00 1,324.35% | 0.02 785.27% | ||
capex to revenue | -0.04 - | -0.04 8.99% | ||||||||||
cash per share | 0.10 - | 0.17 67.19% | 2.40 1,316.19% | 0.57 76.08% | 47.57 8,178.76% | 116.59 145.10% | 66.35 43.10% | 27.94 57.88% | 27.57 1.35% | 11.09 59.76% | 21.81 96.60% | |
days of inventory on hand | 1.67K - | 215.91 87.04% | ||||||||||
days payables outstanding | 779.67 - | 72.69 90.68% | ||||||||||
days sales outstanding | 29.49 - | 22.98 22.07% | ||||||||||
debt to assets | 0.04 - | 0.03 34.59% | 0.06 125.06% | 0.03 55.27% | ||||||||
debt to equity | 0.06 - | 0.04 35.47% | 0.09 139.08% | 0.03 62.94% | ||||||||
dividend yield | ||||||||||||
earnings yield | -2.70 - | -0.06 97.96% | -0.35 539.05% | -0.30 14.07% | -0.12 61.87% | -0.06 48.17% | -0.17 185.67% | -0.20 15.96% | -0.49 149.01% | -3.55 618.60% | -3.51 1.30% | |
enterprise value | 13.14K - | 20.86M 158,683.61% | 9.67M 53.66% | 6.02M 37.74% | 24.60M 308.67% | 89.76M 264.93% | 47.64M 46.93% | 38.35M 19.50% | 14.28M 62.77% | 1.21M 91.55% | -6.25M 618.29% | |
enterprise value over ebitda | -0.28 - | -18.13 6,352.11% | -2.86 84.22% | -3.40 18.86% | -7.31 115.00% | -13.90 90.14% | -4.64 66.61% | -4.47 3.70% | -1.46 67.41% | -0.09 93.72% | 0.81 983.44% | |
ev to operating cash flow | -0.33 - | -32.52 9,619.93% | -6.01 81.51% | -15.59 159.24% | -10.40 33.30% | -25.27 143.00% | -7.13 71.77% | -5.36 24.82% | -1.46 72.81% | -0.08 94.69% | 0.86 1,208.97% | |
ev to sales | 1.11 - | -1.51 236.53% | ||||||||||
free cash flow per share | -0.96 - | -15.34 1,495.86% | -28.86 88.08% | -5.30 81.62% | -22.00 314.77% | -20.82 5.35% | -32.38 55.53% | -34.45 6.38% | -36.43 5.76% | -27.86 23.54% | -3.04 89.07% | |
free cash flow yield | -2.27 - | -0.03 98.64% | -0.16 433.55% | -0.06 61.19% | -0.08 25.54% | -0.03 58.52% | -0.12 251.09% | -0.16 40.60% | -0.46 179.18% | -2.37 417.36% | -3.28 38.53% | |
graham net net | -1.09 - | -1.10 0.52% | 1.69 254.08% | -5.00 395.25% | 45.26 1,005.05% | 112.64 148.86% | 60.83 45.99% | 18.91 68.91% | -1.76K 9,402.88% | 6.82 100.39% | 21.40 213.78% | |
graham number | 5.27 - | 149.69 2,738.07% | 178.31 19.12% | 76.85 56.90% | 200.82 161.31% | 317.55 58.13% | 267.62 15.73% | 158.27 40.86% | 155.78 1.57% | 123.30 20.85% | 19.01 84.58% | |
income quality | 0.84 - | 0.56 33.73% | 0.46 16.50% | 0.21 54.80% | 0.69 227.26% | 0.55 20.26% | 0.66 20.65% | 0.82 24.53% | 0.96 16.49% | 0.84 12.69% | 0.92 9.38% | |
intangibles to total assets | 0 - | 0.88 Infinity% | 0.85 4.17% | 0.88 3.86% | 0.16 81.35% | 0.05 72.27% | 0.06 31.91% | 0.11 78.00% | 0.11 1.86% | 0.16 51.94% | 0.14 16.34% | |
interest coverage | -4.70K - | -679.64 85.55% | -979.95 44.19% | -38.34K 3,812.55% | -6.95K 81.88% | -97.47 98.60% | -469.59 - | -27.54 94.14% | -142.53 417.63% | |||
interest debt per share | 0.00 - | 0.04 15,667.54% | 0.06 56.30% | 0.00 98.96% | 0.00 595.36% | 0.39 8,417.67% | 1.60 - | 2.34 46.18% | 1.59 32.32% | 0.16 89.90% | ||
inventory turnover | 0.22 - | 1.69 671.38% | ||||||||||
invested capital | 0.06 - | 0.04 35.47% | 0.09 139.08% | 0.03 62.94% | ||||||||
market cap | 17.28K - | 20.87M 120,663.30% | 9.80M 53.03% | 6.06M 38.16% | 29.75M 390.95% | 108.11M 263.35% | 57.44M 46.86% | 43.82M 23.71% | 21.37M 51.24% | 6.59M 69.16% | 2.27M 65.60% | |
net current asset value | -44.11K - | 115.61K 362.08% | 139.53K 20.69% | -311.12K 322.98% | 5.06M 1,724.93% | 19.61M 287.98% | 12.94M 34.03% | 4.38M 66.16% | 5.97M 36.43% | 5.89M 1.42% | 9.32M 58.19% | |
net debt to ebitda | 0.09 - | 0.01 93.02% | 0.04 542.46% | 0.02 40.36% | 1.53 6,372.29% | 2.84 85.38% | 0.96 66.38% | 0.64 33.19% | 0.72 13.38% | 0.41 43.58% | 1.10 169.81% | |
net income per share | -1.14 - | -27.48 2,300.66% | -61.90 125.27% | -25.18 59.32% | -31.73 25.99% | -37.52 18.27% | -47.48 26.55% | -41.66 12.27% | -39.30 5.67% | -41.74 6.21% | -3.25 92.21% | |
operating cash flow per share | -0.96 - | -15.30 1,490.81% | -28.77 88.11% | -5.29 81.61% | -21.82 312.31% | -20.57 5.69% | -32.25 56.75% | -34.25 6.19% | -36.42 6.36% | -27.79 23.71% | -2.98 89.28% | |
payables turnover | 0.47 - | 5.02 972.61% | ||||||||||
receivables turnover | 12.38 - | 15.88 28.32% | ||||||||||
research and ddevelopement to revenue | 6.68 - | 0.90 86.50% | ||||||||||
return on tangible assets | -9.17 - | -6.14 33.10% | -16.70 172.00% | -12.36 25.99% | -0.64 94.81% | -0.32 50.44% | -0.69 118.19% | -1.30 87.07% | -1.21 6.69% | -2.19 80.94% | -0.65 70.18% | |
revenue per share | 1.94 - | 1.69 12.94% | ||||||||||
roe | 1.06 - | -0.76 171.55% | -2.71 257.63% | -2.42 10.90% | -0.56 76.75% | -0.31 44.06% | -0.71 125.51% | -1.56 120.08% | -1.43 8.14% | -2.58 80.06% | -0.66 74.50% | |
roic | 1.06 - | -0.76 171.76% | -2.71 257.63% | -2.42 10.90% | -0.56 76.75% | -0.31 44.66% | -0.73 133.83% | -1.41 94.02% | -1.30 7.97% | -1.62 24.53% | -636.21 39,270.05% | |
sales general and administrative to revenue | 6.30 - | 1.41 77.57% | ||||||||||
shareholders equity per share | -1.08 - | 36.24 3,455.19% | 22.83 37.01% | 10.42 54.34% | 56.49 441.97% | 119.45 111.43% | 67.03 43.88% | 26.72 60.14% | 27.44 2.70% | 16.19 41.01% | 4.94 69.46% | |
stock based compensation to revenue | 0.71 - | 0.07 90.58% | ||||||||||
tangible asset value | -44.11K - | 117.60K 366.60% | 144.62K 22.98% | -307.46K 312.60% | 5.08M 1,751.00% | 19.66M 287.22% | 12.98M 33.96% | 4.78M 63.17% | 6.31M 32.08% | 6.97M 10.37% | 10.14M 45.54% | |
tangible book value per share | -1.08 - | 2.80 359.62% | 2.59 7.70% | -4.21 262.79% | 46.82 1,211.04% | 113.84 143.16% | 62.68 44.94% | 22.90 63.47% | 23.49 2.61% | 8.82 62.46% | 4.15 52.97% | |
working capital | -44.11K - | 115.61K 362.08% | 139.53K 20.69% | -311.12K 322.98% | 5.06M 1,724.93% | 19.61M 287.98% | 12.94M 34.03% | 4.63M 64.25% | 6.16M 33.22% | 6.28M 1.87% | 9.33M 48.63% |
All numbers in USD (except ratios and percentages)